Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale

Sajid, S., Lawrence, R. E., Galfalvy, H. C., Keilp, J. G., Moitra, V. K., Mann, J. J., & Grunebaum, M. F. (2024). Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale. Journal of Affective Disorders Reports, 15, 100690. https://doi.org/10.1016/j.jadr.2023.100690
Authors:
Sumra Sajid
Ryan E. Lawrence
Hanga Galfalvy
John G. Keilp
Vivek K. Moitra
J. John Mann
Michael F. Grunebaum
Affiliated Authors:
Sumra Sajid
Ryan E. Lawrence
Hanga Galfalvy
John G. Keilp
Vivek K. Moitra
J. John Mann
Michael F. Grunebaum
Author Keywords:
clinical trial design
emergency department
intramuscular
ketamine
suicide
Publication Type:
Article
Unique ID:
10.1016/j.jadr.2023.100690
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: